Login / Signup

Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment.

Nibal ChamounHady GhanemAhmad HachemEssa HaririChristelle LteifHanine MansourHani DimassiRichard ZalloumGeorges Ghanem
Published in: BMC pharmacology & toxicology (2019)
The trial was retrospectively registered on ClinicalTrials.gov identifier: NCT03158792 . Registered: May 18, 2017.
Keyphrases
  • venous thromboembolism
  • study protocol
  • phase iii
  • clinical trial
  • middle aged
  • phase ii
  • community dwelling
  • open label